Study by Jason Karlawish (PARC Research Associate) and collaborators that investigated physician-assisted death attitudes among those with an Alzheimer disease biomarker was highlighted as a “Best Advance of 2019 in Cognitive Neurology/Dementia” by Neurology Today.